KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Assets (2018 - 2025)

Historic Return on Assets for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.02%.

  • Amneal Pharmaceuticals' Return on Assets rose 600.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.02% for FY2024, which is 100.0% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Return on Assets of 0.02% as of Q3 2025, which was up 600.0% from 0.02% recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Return on Assets high stood at 0.02% for Q3 2025, and its period low was 0.07% during Q1 2023.
  • In the last 5 years, Amneal Pharmaceuticals' Return on Assets had a median value of 0.01% in 2021 and averaged 0.02%.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Return on Assets skyrocketed by 800bps in 2021 and then crashed by -800bps in 2022.
  • Amneal Pharmaceuticals' Return on Assets (Quarter) stood at 0.01% in 2021, then tumbled by -1400bps to 0.07% in 2022, then soared by 79bps to 0.01% in 2023, then tumbled by -56bps to 0.02% in 2024, then soared by 177bps to 0.02% in 2025.
  • Its Return on Assets was 0.02% in Q3 2025, compared to 0.02% in Q2 2025 and 0.01% in Q1 2025.